Biocept Company Insiders
| BIOCQ Stock | 0.0001 0.0001 50.00% |
Biocept employs about 50 people. The company is managed by 3 executives with a total tenure of roughly 117 years, averaging almost 39.0 years of service per executive, having 16.67 employees per reported executive. Discussion of Biocept's management performance can provide insight into the enterprise performance.
Biocept Management Team Effectiveness
The company has return on total asset (ROA) of (0.5165) % which means that it has lost $0.5165 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8694) %, meaning that it generated substantial loss on money invested by shareholders. Biocept's management efficiency ratios could be used to measure how well Biocept manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/29/2025, Return On Tangible Assets is likely to drop to -0.98. In addition to that, Return On Capital Employed is likely to drop to -1.52. At this time, Biocept's Total Current Liabilities is relatively stable compared to the past year. As of 12/29/2025, Liabilities And Stockholders Equity is likely to grow to about 43 M, while Non Current Liabilities Total is likely to drop slightly above 11 M.As of 12/29/2025, Common Stock Shares Outstanding is likely to drop to about 418.4 K
Biocept Workforce Comparison
Biocept is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 552. Biocept holds roughly 50.0 in number of employees claiming about 9% of equities under Health Care industry.
Biocept Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biocept Price Series Summation is a cross summation of Biocept price series and its benchmark/peer.
Biocept Notable Stakeholders
A Biocept stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biocept often face trade-offs trying to please all of them. Biocept's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biocept's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Soon Hahn | Founder | Profile | |
| Pavel Tsinberg | Director Development | Profile | |
| Veena Singh | Senior Director | Profile |
About Biocept Management Performance
The success or failure of an entity such as Biocept often depends on how effective the management is. Biocept management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biocept management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biocept management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.94) | (0.98) | |
| Return On Capital Employed | (1.45) | (1.52) | |
| Return On Assets | (0.94) | (0.98) | |
| Return On Equity | (4.16) | (3.96) |
Biocept Workforce Analysis
Traditionally, organizations such as Biocept use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biocept within its industry.Biocept Manpower Efficiency
Return on Biocept Manpower
| Revenue Per Employee | 517.2K | |
| Revenue Per Executive | 8.6M | |
| Net Loss Per Employee | 641.7K | |
| Net Loss Per Executive | 10.7M | |
| Working Capital Per Employee | 216.7K | |
| Working Capital Per Executive | 3.6M |
Additional Tools for Biocept Stock Analysis
When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.